Stocks›Healthcare

ABATE AS INDUSTRIES LIMITED

ABATEAS · BSE · Healthcare · As of 8 Nov 2026

₹7.40

+₹0.38 (+5.41%)(1D)

₹6.1652 Week Range₹20.11

Market Cap

₹183.61 Cr

P/E (Sector)

74.0 (32.3)

P/B Ratio

—

Dividend Yield

—

ROE

0.7%

Debt / Equity

—

Anvest Score

25/100

Valuation

0/100

Quality

3/100

Growth

27/100

Health

100/100

Momentum

13/100

Valuation
0
Quality
3
Growth
27
Health
100
Momentum
13

AI Company ProfileFiling-backed

AI Snapshot

Abate As Industries Ltd operates in the healthcare sector, specifically hospitals, primarily serving the Indian market.

HospitalFounded:1991CEO/MD:Muhemmed SwadiqueHQ:Perinthalmanna, Kerala

Business profile as of period ended 25 Aug 2026

Business at a Glance

Costs include purchase, duties, taxes, and other costs to bring inventory to its location and condition.
Inventory costs are determined on a weighted average basis.

What Looks Strong

No material strength identified from currently verified evidence.

What to Watch

ValuationThe shares trade at 72× trailing earnings; the multiple assumes sustained high growth and is sensitive to any slowdown.
MarketShares have lagged the Nifty 500 by 21.4 percentage points annualized over three years.
TrendPrice is 32% below its 200-day moving average, indicating a weak long-term price trend.

Loading company profile…

Fundamentals

P/E Ratio (TTM)

Sector median P/E

32.29

P/B Ratio

—

Sector median P/B

4.4

EPS (TTM)

₹0.1

Market Cap

₹183.61 Cr

ROE

0.69%

ROCE

0.69%

Profit Margin

7.6%

ABATE AS INDUSTRIES LIMITED FAQs

3 topics

Expand

What does the ABATE AS INDUSTRIES LIMITED (ABATEAS) stock page cover?

ABATE AS INDUSTRIES LIMITED on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for ABATEAS?

ABATE AS INDUSTRIES LIMITED is currently shown with a delayed price near ₹7.4, P/E 74, and ROE 0.69%.

Does the ABATEAS page provide investment advice?

No. The ABATEAS page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring